PAI1 mediates fibroblast-mast cell interactions in skin fibrosis
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
Fibrosis is a prevalent pathological condition arising from the chronic activation of fibroblasts. This activation results from the extensive intercellular crosstalk mediated by both soluble factors and direct cell-cell connections. Prominent among these are the interactions of fibroblasts with immune cells, in which the fibroblast-mast cell connection, although acknowledged, is relatively unexplored. We have used a Tg mouse model of skin fibrosis, based on expression of the transcription factor Snail in the epidermis, to probe the mechanisms regulating mast cell activity and the contribution of these cells to this pathology. We have discovered that Snail-expressing keratinocytes secrete plasminogen activator inhibitor type 1 (PAI1), which functions as a chemotactic factor to increase mast cell infiltration into the skin. Moreover, we have determined that PAI1 upregulates intercellular adhesion molecule type 1 (ICAM1) expression on dermal fibroblasts, rendering them competent to bind to mast cells. This heterotypic cell-cell adhesion, also observed in the skin fibrotic disorder scleroderma, culminates in the reciprocal activation of both mast cells and fibroblasts, leading to the cascade of events that promote fibrogenesis. Thus, we have identified roles for PAI1 in the multifactorial program of fibrogenesis that expand its functional repertoire beyond its canonical role in plasmin-dependent processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, mast cells can directly interact with skin (myo) fibroblasts, and this facilitates their role in fibrosis.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [162]
The cited source says what the claim attributes to it.
In the citing paper
“Apart from the aforementioned role as inhibitor of plasmin activation, this protein is a chemotactic for mast cells and induces the expression of intercellular adhesion molecule 1 (ICAM1) in fibroblasts, which is needed for mast cells to adhere to fibroblasts (162).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [162]
In the citing paper
“This interaction was shown to be serpine1 dependent.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“Consequently, fibrosis is often associated with cancer (2), scleroderma (3), and numerous other connective tissue disorders (4, 5).”
BackgroundRGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“Interestingly, the LDV peptides can be recognized by integrins (59).”
BackgroundChemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059 · cited 1×
“These cytokines have also been implicated in neutrophil, NK cell, and T cell migration and activation (66).”
BackgroundTargeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · cited 2×
“The existence of these simultaneously operating mechanisms makes it evident why inhibitors of IL-4 or TGF-β alone are yielding disappointing results as antifibrotic targets in clinical trials (33, 34).”
BackgroundMacrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392 · cited 1×
“Various cells including neutrophils (6), macrophages (7), and mast cells (8, 9) have been shown to be sources of a number of fibroblast-activating cytokines and/or chemokines.”
BackgroundHenderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866
Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.1987 · Cited by 703
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Ghosh, A. K., & Vaughan, D. E. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22783 · Cited by 679 · cited 10×
“Consistent with these observations, the removal of Pai1 has also been shown to rescue the disease phenotype (22, 26, 27).”
BackgroundMethodResultInfluentialThe serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 674
Pulmonary fibrosis: patterns and perpetrators
Noble, P. W., Barkauskas, C. E., & Jiang, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60323 · Cited by 595 · cited 1×
“Consequently, fibrosis is often associated with cancer (2), scleroderma (3), and numerous other connective tissue disorders (4, 5).”
BackgroundMicroRNA‐29, a key regulator of collagen expression in systemic sclerosis
Maurer, B., Stanczyk, J., Jüngel, A., Akhmetshina, A., Trenkmann, M., Brock, M., Kowal‐Bielecka, O., Gay, R. E., Michel, B. A., Distler, J. H. W., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27443 · Cited by 539 · cited 1×
“It has been reported that the microRNA miR29a regulates Col expression in fibrotic conditions such as systemic sclerosis (37).”
BackgroundZeisberg, M., & Kalluri, R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2012 · Cited by 462
The role of tenascin-C in tissue injury and tumorigenesis
Midwood, K. S., & Orend, G. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0075-1 · Cited by 438
Cytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375 · cited 1×
“The existence of these simultaneously operating mechanisms makes it evident why inhibitors of IL-4 or TGF-β alone are yielding disappointing results as antifibrotic targets in clinical trials (33, 34).”
BackgroundIL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent
Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4020 · Cited by 370 · cited 1×
“A subsequent outcome of this heterotypic interaction is the production in activated mast cells of the profibrotic interleukins IL-4 and IL-13, which are likely candidates for the induction of fibroblast proliferation (73, 74).”
BackgroundSnail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney
Boutet, A., De Frutos, C. A., Maxwell, P. H., Mayol, M. J., Romero, J., & Nieto, M. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601421 · Cited by 327 · cited 1×
“Consequently, fibrosis is often associated with cancer (2), scleroderma (3), and numerous other connective tissue disorders (4, 5).”
BackgroundActivated mast cells produce interleukin 13.
Burd, P. R., Thompson, W. C., Max, E. E., & Mills, F. C. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1373 · Cited by 314
Czekay, R.-P., Aertgeerts, K., Curriden, S. A., & Loskutoff, D. J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208117 · Cited by 304 · cited 1×
“Also important in fibrosis is the ability of PAI1 to regulate intracellular signaling in fibroblasts and other cell types through the urokinase/tissue plasminogen activator receptors and integrins on the cell surface (22, 31, 32).”
BackgroundGessner, A., Mohrs, K., & Mohrs, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1063 · Cited by 302
Integrin structures and conformational signaling
Luo, B.-H., & Springer, T. A. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.005 · Cited by 295 · cited 1×
“We hypothesized that this pathway should be activated merely by external addition of the RGD peptide (49, 50), which is the integrin-binding motif found on ECM proteins such as fibronectin.”
BackgroundMechanistic connection between inflammation and fibrosis
Lee, S. B., & Kalluri, R. (2010) · Kidney International · doi:10.1038/ki.2010.418 · Cited by 286
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction
Oda, T., Jung, Y. O., Kim, H. S., Cai, X., López-Guisa, J. M., Ikeda, Y., & Eddy, A. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.030002587.x · Cited by 274 · cited 4×
“The loss of PAI1 expression has also been correlated with decreasing neutrophil and macrophage numbers in renal fibrosis (27, 64), indicating that its function as a chemokine might be extended to other immune cells.”
BackgroundMethodResultInfluentialBleomycin-induced pulmonary fibrosis in fibrinogen-null mice
Hattori, N., Degen, J. L., Sisson, T. H., Liu, H., Moore, B. B., Pandrangi, R. G., Simon, R. H., & Drew, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10531 · Cited by 265 · cited 1×
“However, genetic ablation of fibrinogen or inhibition of PAI1 binding to the plasminogen activators did not rescue the fibrotic phenotype to the same extent as the deletion of Pai1 did (28, 29).”
BackgroundGarbuzenko, E., Nagler, A., Pickholtz, D., Gillery, P., Reich, R., Maquart, F. ‐., & Levi‐Schaffer, F. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01293.x · Cited by 225 · cited 1×
“Although there are numerous reports documenting an increase in mast cell numbers in various fibrotic scenarios (8, 11, 76, 77) including the skin fibrotic condition of scleroderma (11, 44, 78), there are nevertheless suggestions that these cells are not limiting factors in fibrosis development (79–81).”
BackgroundPlasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles
Binder, B. R., Christ, G., Gruber, F., Grubic, N., Hufnagl, P., Krebs, M., Mihaly, J., & Prager, G. W. (2002) · Physiology · doi:10.1152/nips.01369.2001 · Cited by 225 · cited 2×
“Deletion of the Pai1 gene in the Snail-Tg mouse (Snail-Tg/Pai1-KO) was also not accompanied by a significant increase in PAI2 or PAI3 levels in either neonatal or adult tissues (Supplemental Figure 1E).”
BackgroundMast cell production and response to IL-4 and IL-13
McLeod, J. J. A., Baker, B., & Ryan, J. J. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.019 · Cited by 208
Yu, C.-H., Law, J. B. K., Suryana, M., Low, H. Y., & Sheetz, M. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109485108 · Cited by 205 · cited 1×
“We hypothesized that this pathway should be activated merely by external addition of the RGD peptide (49, 50), which is the integrin-binding motif found on ECM proteins such as fibronectin.”
BackgroundPAI‐1, progress in understanding the clinical problem and its aetiology
Iwaki, T., Urano, T., & Umemura, K. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09074.x · Cited by 177 · cited 2×
“One of the factors secreted by these Tg cells is a serpin family protein, the plasminogen activator inhibitor type 1 (PAI1), often reported to be highly expressed in various fibrotic tissues (22, 23).”
BackgroundMechanisms of skin fibrosis in systemic sclerosis
JINNIN, M. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00738.x · Cited by 173 · cited 1×
“Consequently, fibrosis is often associated with cancer (2), scleroderma (3), and numerous other connective tissue disorders (4, 5).”
BackgroundPlasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis
Rabieian, R., Boshtam, M., Zareei, M., Kouhpayeh, S., Masoudifar, A., & Mirzaei, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26146 · Cited by 161 · cited 1×
“Although the antifibrinolytic functions of PAI1 have received most of the attention, more recent data demonstrate a correlation between heightened PAI1 expression and inflammation in numerous fibrotic conditions (22, 29, 30).”
BackgroundThe Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis
Flevaris, P., & Vaughan, D. (2016) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1586228 · Cited by 159 · cited 1×
“The role of PAI1 in these cases has been credited to its antifibrinolytic function, in which the loss of plasmin and MMP activity leads to the accumulation of fibrin and other ECM components (22, 24, 25).”
BackgroundTherapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells
Jakubzick, C., Choi, E. S., Joshi, B. H., Keane, M. P., Kunkel, S. L., Puri, R. K., & Hogaboam, C. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2684 · Cited by 157 · cited 1×
“This is supported by the findings that targeting IL-4 receptor– and IL-13 receptor–expressing cells, including fibroblasts, can cause attenuation of lung fibrosis (75).”
BackgroundMast cell activity in the healing wound: more than meets the eye?
Wulff, B. C., & Wilgus, T. A. (2013) · Experimental Dermatology · doi:10.1111/exd.12169 · Cited by 155
Manetti, M., Guiducci, S., Ruffo, M., Rosa, I., Faussone‐Pellegrini, M. S., Matucci‐Cerinic, M., & Ibba‐Manneschi, L. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12028 · Cited by 155 · cited 1×
“The presence of mast cell–adherent fibroblasts in the skin of patients with scleroderma highlights the potential importance of this phenomenon in therapeutic development (42, 67, 68).”
BackgroundHashimoto, S., Gon, Y., Takeshita, I., Maruoka, S., & Horie, T. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.114702 · Cited by 151 · cited 1×
“A subsequent outcome of this heterotypic interaction is the production in activated mast cells of the profibrotic interleukins IL-4 and IL-13, which are likely candidates for the induction of fibroblast proliferation (73, 74).”
BackgroundA Signaling Pathway Involving TGF-β2 and Snail in Hair Follicle Morphogenesis
Jamora, C., Lee, P., Kocieniewski, P., Azhar, M., Hosokawa, R., Chai, Y., & Fuchs, E. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0030011 · Cited by 147 · cited 3×
“Consistent with the notion that SNAIL is a causal factor in cutaneous fibrosis, we previously reported (35) that the transcription factor Snail targeted to the basal layer of the epidermis via the keratin-14 promoter is sufficient to induce phenotypes that are hallmarks of fibrosis.”
BackgroundMethodInfluentialSelf-citationPAI-1, fibrosis, and the elusive provisional fibrin matrix
Loskutoff, D. J., & Quigley, J. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11765 · Cited by 143 · cited 1×
“Our observations are consistent with reports that correlate elevated PAI1 levels with tissue inflammation in various fibrotic scenarios (22, 27, 41).”
ResultMast cells: the forgotten cells of renal fibrosis
Roberts, I. S. D., & Brenchley, P. E. C. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.11.858 · Cited by 135
Artuc, M., Steckelings, U. M., & Henz, B. M. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01705.x · Cited by 134 · cited 2×
“org Volume 128 Number 5 May 2018 ed with fibroblast activation by the release of fibroblast-activating substances as well as cell-cell adhesion (12, 43).”
BackgroundWysocki, A. B., Kusakabe, A. O., Chang, S. L., & Tuan, T. (1999) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1999.00154.x · Cited by 131 · cited 1×
“Consistent with this hypothesis, it has been previously observed that PAI1 expression increases upon wounding as early as 1 day after injury (46).”
BackgroundMast cells in the pathogenesis of fibrosis
Gruber, B. L. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0043-3 · Cited by 130 · cited 3×
“An upregulation of mast cell numbers has been observed in numerous fibrotic disorders (8, 9, 11), but the mechanism by which their numbers are regulated within tissues remains elusive.”
BackgroundHepatocyte-Derived Snail1 Propagates Liver Fibrosis Progression
Rowe, R. G., Lin, Y., Shimizu-Hirota, R., Hanada, S., Neilson, E. G., Greenson, J. K., & Weiss, S. J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01218-10 · Cited by 125
Deficiency of tenascin‐C attenuates liver fibrosis in immune‐mediated chronic hepatitis in mice
El‐Karef, A., Yoshida, T., Gabazza, E., Nishioka, T., Inada, H., Sakakura, T., & Imanaka‐Yoshida, K. (2007) · The Journal of Pathology · doi:10.1002/path.2099 · Cited by 120
Chemokine Receptor Expression by Mast Cells
Juremalm, M., & Nilsson, G. (2005) · Chemical Immunology and Allergy · doi:10.1159/000087640 · Cited by 119 · cited 1×
“This includes the receptors for CXCL5 and CXCL11, which are expressed by human mast cells (65).”
BackgroundMast Cell Numbers in Diffuse Scleroderma
Nishioka, K., Kobayashi, Y., Katayama, I., & Takijiri, C. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660260075017 · Cited by 117 · cited 2×
“Although there are numerous reports documenting an increase in mast cell numbers in various fibrotic scenarios (8, 11, 76, 77) including the skin fibrotic condition of scleroderma (11, 44, 78), there are nevertheless suggestions that these cells are not limiting factors in fibrosis development (79–81).”
BackgroundHogaboam, C. M., Kunkel, S. L., Strieter, R. M., Taub, D. D., Lincoln, P., Standiford, T. J., & Lukacs, N. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6166 · Cited by 112 · cited 7×
“Our results are further corroborated by earlier reports showing that neutralization of the β1 integrin chain on mast cells, which is known to mediate fibrinogen binding, and also of the c-Kit ligand on mast cells, which mediates binding to SCF (55), does not inhibit fibroblast mast cell adhesion.”
BackgroundInfluentialConese, M., Copreni, E., Gioia, S. D., Rinaldis, P. D., & Fumarulo, R. (2003) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(03)00063-8 · Cited by 111 · cited 1×
“Various cells including neutrophils (6), macrophages (7), and mast cells (8, 9) have been shown to be sources of a number of fibroblast-activating cytokines and/or chemokines.”
BackgroundTrautmann, A., Krohne, G., Bröcker, E.-B., & Klein, C. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.5053 · Cited by 107 · cited 2×
“Increased mast cell numbers have been implicated in fibroblast activation via heterotypic cell-cell adhesion in many fibrotic tissues (16, 43).”
BackgroundVarga, J., & Pasche, B. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32830e48e8 · Cited by 107 · cited 1×
“Our work with the Snail-Tg mouse reinforces the opinion that fibrosis is a complex disorder with multiple parallel processes and provides a potential explanation for the lack of success of anti–TGF-β therapy so far (33, 82).”
BackgroundAre mast cells instrumental for fibrotic diseases?
Overed-Sayer, C., Rapley, L., Mustelin, T., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00174 · Cited by 105 · cited 9×
“An upregulation of mast cell numbers has been observed in numerous fibrotic disorders (8, 9, 11), but the mechanism by which their numbers are regulated within tissues remains elusive.”
BackgroundInfluentialMast Cells and Fibroblasts Work in Concert to Aggravate Pulmonary Fibrosis
Wygrecka, M., Dahal, B. K., Kosanovic, D., Petersen, F., Taborski, B., von Gerlach, S., Didiasova, M., Zakrzewicz, D., Preissner, K. T., Schermuly, R. T., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.02.013 · Cited by 102 · cited 3×
“Increased mast cell numbers have been implicated in fibroblast activation via heterotypic cell-cell adhesion in many fibrotic tissues (16, 43).”
BackgroundLee, S.-W., Won, J.-Y., Kim, W. J., Lee, J., Kim, K.-H., Youn, S.-W., Kim, J.-Y., Lee, E. J., Kim, Y.-J., Kim, K.-W., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.146 · Cited by 102
The matrix protein Fibulin-5 is at the interface of tissue stiffness and inflammation in fibrosis
Nakasaki, M., Hwang, Y., Xie, Y., Kataria, S., Gund, R., Hajam, E. Y., Samuel, R., George, R., Danda, D., Paul, M. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9574 · Cited by 92 · cited 4×
“We have previously shown that other factors secreted from the Snail-Tg keratinocytes, such as fibulin 5 (17) contribute in different ways to the development of skin fibrosis.”
BackgroundMethodResultInfluentialSelf-citationTuan, T., Wu, H., Huang, E. Y., Chong, S., Laug, W. E., Messadi, D. V., Kelly, P., & Lê, A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64292-7 · Cited by 87 · cited 2×
“PAI1 is known to contribute to the accumulation of collagen in keloid fibroblasts and other fibrotic conditions (22, 24, 27), and likewise the transcript levels of collagens 1, 3, and 4 (Col1, -3, and -4), the major collagens in the dermis, increased in the Snail-Tg mouse but returned to WT levels when the Pai1 gene w…”
BackgroundNakayamada, S., Okada, Y., Saito, K., Tamura, M., & Tanaka, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308786200 · Cited by 84 · cited 1×
“One of these is the intercellular adhesion molecule (ICAM) family, and in particular ICAM1, which has been reported to be upregulated through FAK activation (56).”
BackgroundBeyond allergy: the role of mast cells in fibrosis
Hügle, T. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13999 · Cited by 79 · cited 4×
“The presence of mast cell–adherent fibroblasts in the skin of patients with scleroderma highlights the potential importance of this phenomenon in therapeutic development (42, 67, 68).”
BackgroundInfluentialWillenborg, S., Eckes, B., Brinckmann, J., Krieg, T., Waisman, A., Hartmann, K., Roers, A., & Eming, S. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.12 · Cited by 74
Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis
Shields, M. A., Ebine, K., Sahai, V., Kumar, K., Siddiqui, K., Hwang, R. F., Grippo, P. J., & Munshi, H. G. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0637 · Cited by 67
Du, F., Nakamura, Y., Tan, T.-L., Lee, P., Lee, R., Yu, B., & Jamora, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0324 · Cited by 65 · cited 2×
“As we have previously reported (17, 18), the numbers of macrophages and mast cells are significantly higher in neonatal Snail-Tg skin.”
MethodResultSelf-citationRole of mast cells in the development of renal fibrosis: Use of mast cell–deficient rats
Miyazawa, S., Hotta, O., Doi, N., Natori, Y., Nishikawa, K., & Natori, Y. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00629.x · Cited by 65
Effect of mast cell chymase inhibitor on the development of scleroderma in tight‐skin mice
Shiota, N., Kakizoe, E., Shimoura, K., Tanaka, T., & Okunishi, H. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706209 · Cited by 49 · cited 1×
“Although there are numerous reports documenting an increase in mast cell numbers in various fibrotic scenarios (8, 11, 76, 77) including the skin fibrotic condition of scleroderma (11, 44, 78), there are nevertheless suggestions that these cells are not limiting factors in fibrosis development (79–81).”
BackgroundRat mast cells communicate with fibroblasts via gap junction intercellular communications
Au, S. R., Au, K., Saggers, G. C., Karne, N. K., & Ehrlich, H. P. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21107 · Cited by 47 · cited 1×
“Among these are membrane-bound stem cell factor (SCF) (15), hyaluronic acid receptors (52), fibrinogen (53), and gap junctions (54).”
BackgroundMast cells and fibrosis. The relevance to scleroderma.
Claman, H. N. (1990) · PubMed · Cited by 47
Pedroja, B. S., Kang, L. E., Imas, A., Carmeliet, P., & Bernstein, A. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018804 · Cited by 44 · cited 1×
“PAI1 is known to mediate intracellular signaling via the regulation of cell-surface integrins by unmasking the available RGD motif– binding site (47, 48).”
BackgroundPlasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis
Roelofs, J. J. T. H., Teske, G. J. D., Bonta, P. I., de Vries, C. J. M., Meijers, J. C. M., Weening, J. J., van der Poll, T., & Florquin, S. (2008) · Kidney International · doi:10.1038/ki.2008.454 · Cited by 44 · cited 1×
“The loss of PAI1 expression has also been correlated with decreasing neutrophil and macrophage numbers in renal fibrosis (27, 64), indicating that its function as a chemokine might be extended to other immune cells.”
BackgroundThe role of mast cells in the development of skin fibrosis in tight-skin mutant mice
Everett, E. T., Pablos, J. L., Harley, R. A., LeRoy, E. C., & Norris, J. S. (1995) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(94)00127-f · Cited by 41 · cited 1×
“Although there are numerous reports documenting an increase in mast cell numbers in various fibrotic scenarios (8, 11, 76, 77) including the skin fibrotic condition of scleroderma (11, 44, 78), there are nevertheless suggestions that these cells are not limiting factors in fibrosis development (79–81).”
BackgroundHeterotypic cell-cell adhesion of human mast cells to fibroblasts
Trautmann, A., Feuerstein, B., Ernst, N., Bröcker, E. B., & Klein, C. E. (1997) · Archives of Dermatological Research · doi:10.1007/s004030050180 · Cited by 41 · cited 6×
“Our results are further corroborated by earlier reports showing that neutralization of the β1 integrin chain on mast cells, which is known to mediate fibrinogen binding, and also of the c-Kit ligand on mast cells, which mediates binding to SCF (55), does not inhibit fibroblast mast cell adhesion.”
ResultInfluentialOki, T., Kitaura, J., Eto, K., Yang, L., Maeda‐Yamamoto, M., Inagaki, N., Nagai, H., Yamanishi, Y., Nakajina, H., Kumagai, H., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.52 · Cited by 41
Integrin receptor specificity for human red cell ICAM‐4 ligand
Hermand, P., Gane, P., Callebaut, I., Kieffer, N., Cartron, J., & Bailly, P. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04313.x · Cited by 41
Lemaire, R., Burwell, T. J., Sun, H. C., Delaney, T. A., Bakken, J., Cheng, L., Rebelatto, M. C., Czapiga, M., de‐Mendez, I., Coyle, A. J., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39443 · Cited by 41
Vial, D., & McKeown‐Longo, P. J. (2008) · Journal of Cell Science · doi:10.1242/jcs.020149 · Cited by 38 · cited 2×
“It has previously been reported that PAI1 releases αV integrin from the soluble glycoprotein vitronectin (31, 51).”
BackgroundKoma, Y., Ito, A., Watabe, K., Hirata, T., Mizuki, M., Yokozaki, H., Kitamura, T., Kanakura, Y., & Kitamura, Y. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700231 · Cited by 37
Insights into integrin-ligand binding and activation from the first crystal structure.
Humphries, M. J. (2002) · Arthritis Research · doi:10.1186/ar563 · Cited by 37
MAST CELLS INDUCE ACTIVATION OF HUMAN LUNG FIBROBLASTS IN VITRO
Garbuzenko, E., Berkman, N., Puxeddu, I., Kramer, M. R., Nagler, A., & Levi‐Schaffer, F. (2004) · Experimental Lung Research · doi:10.1080/01902140490517809 · Cited by 35 · cited 1×
“In recent years, it has also been observed that, apart from the mast cell secretome, which consists of fibroblast-activating substances (12, 13), a direct adhesion between these 2 cell types has also been found to be a prerequisite for fibroblast activation (14–16).”
BackgroundCho, S., Kang, J., Lyttle, C. S., Harris, K. E., Daley, B., Grammer, L. C., Avila, P. C., Kumar, R., & Schleimer, R. P. (2011) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2010.12.021 · Cited by 35 · cited 1×
“Consistent with these observations, the removal of Pai1 has also been shown to rescue the disease phenotype (22, 26, 27).”
MethodStefansson, S., Su, E. J., Ishigami, S., Cale, J. M., Gao, Y., Gorlatova, N. V., & Lawrence, D. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702125200 · Cited by 33 · cited 1×
“It has previously been reported that PAI1 releases αV integrin from the soluble glycoprotein vitronectin (31, 51).”
BackgroundGupta, K. K., Donahue, D. L., Sandoval-Cooper, M. J., Castellino, F., & Ploplis, V. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120728 · Cited by 27 · cited 1×
“Our findings are in line with earlier reports suggesting that during kidney injury, ablation of PAI1 expression or inhibition of its interaction with vitronectin reduces LPS-dependent ICAM1 expression (69).”
ResultKnab, L. M., Ebine, K., Chow, C. R., Raza, S. S., Sahai, V., Patel, A. P., Kumar, K., Bentrem, D. J., Grippo, P. J., & Munshi, H. G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0111 · Cited by 20 · cited 1×
“Interestingly, the secretome from Snail-expressing pancreatic ductal adenocarcinoma tumors has been implicated in the induction of mast cell infiltration (63).”
BackgroundIntercellular interactions between mast cells and fibroblasts promote pro-inflammatory signaling
Termei, R., Laschinger, C. A., Lee, W., & McCulloch, C. A. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.032 · Cited by 17 · cited 1×
“Among these are membrane-bound stem cell factor (SCF) (15), hyaluronic acid receptors (52), fibrinogen (53), and gap junctions (54).”
BackgroundDifferential expression of integrin subunits on adherent and nonadherent mast cells
Grodzki, A. C., Pastor, M. V. D., Sousa, J. F., Oliver, C., & Jamur, M. C. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000800017 · Cited by 17 · cited 1×
“org Volume 128 Number 5 May 2018 dermal fibroblasts plays a key role in mast cell adhesion suggest that the integrins α4β1 or αIIββ3 may function as ligands on the mast cells (53, 58, 71).”
BackgroundCell-to-cell contact of activated mast cells with fibroblasts and lymphocytes in systemic sclerosis
Hügle, T., White, K., & van Laar, J. M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200809 · Cited by 13 · cited 1×
“The presence of mast cell–adherent fibroblasts in the skin of patients with scleroderma highlights the potential importance of this phenomenon in therapeutic development (42, 67, 68).”
Background
Cited by
Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring
El Ayadi, A., Jay, J. W., & Prasai, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031105 · Cited by 246
“A very recent report showed that PAI-1 regulates fibrosis by mediating the effects of mast cells on fibroblasts, therefore regulating collagen secretion by these cells [174].”
BackgroundDiet and Skin Aging—From the Perspective of Food Nutrition
Cao, C., Xiao, Z., Wu, Y., & Ge, C. (2020) · Nutrients · doi:10.3390/nu12030870 · Cited by 231
“Fibroblasts are also involved in skin aging [8], carcinogenesis [9], wound healing [10], fibrosis [11], and other pathological processes.”
BackgroundThe immunopathogenesis of fibrosis in systemic sclerosis
Brown, M., & O’Reilly, S. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13238 · Cited by 190
Pathophysiology of systemic sclerosis (scleroderma)
Rosendahl, A., Schönborn, K., & Krieg, T. (2022) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12505 · Cited by 160
“Mast cells are attracted into fibrotic lesions by local PAI (plasminogen activator inhibitor) signaling stemming from epidermal keratinocytes.(42) Their infiltration can precede the first pathological”
BackgroundUnraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Metadata
- Authors
- Pincha, N., Hajam, E. Y., Badarinath, K., Batta, S. P. R., Masudi, T., Dey, R., Andreasen, P., Kawakami, T., Samuel, R., George, R., Danda, D., Jacob, P. M., & Jamora, C.
- Affiliations
- Manipal Academy of Higher Education (IN)
- Institute for Stem Cell Biology and Regenerative Medicine (IN)
- National Centre for Biological Sciences (IN)
- Aarhus University (DK)
- La Jolla Institute for Immunology (US)
- Christian Medical College, Vellore (IN)
- Corresponding author
- Jamora, Colin
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-03-26
- Volume
- 128
- Issue
- 5
- Pages
- 1807-1819
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5919880
- OpenAlex
- W2790811974
- Cited by
- 70
- References
- 83
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 14 · 2019: 7 · 2018: 5
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology (BT/PR8738/AGR/36/770/2013, BT/PR5981/MED/31/181/2012;2013-2016)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5RO1AR053185-05)
- American Cancer Society (115457-RSG-08-164-01-DDC)
- University of California, San Diego (Hellman Faculty Fellowship)
- Indian Council of Medical Research (ICMR-SRF)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- plasminogen activator inhibitor-1, skin fibrosis, mast cell infiltration, snails, keratinocytes, ICAM-1, systemic sclerosis, fibrogenesis
- MeSH terms
- Animals, Cell Communication, Epidermis, Fibroblasts, Fibrosis, Mast Cells, Skin Diseases, Up-Regulation, Mice, Knockout, Intercellular Adhesion Molecule-1, Mice, Serpin E2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.